ALT-801

DB15386InvestigationalProtein Based Therapies

ALT-801 is under investigation in clinical trial NCT01478074 (ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia).

Mechanism: Pharmacologically active on Glucagon receptor, Glucagon-like peptide 1 receptor, and Cellular tumor antigen p53
Curator reviewed
Code names: ALT-801

Resolves to

Compound

UNIIQWZ40O5W6KCAS1188450-53-4

Targets

P47871GCGRP43220GLP1RP04637TP53P79603HLA-A*02

What you can answer from here — as of July 08, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

11Clinical trialsPhase, status and sponsor resolved per trial

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with ALT-801, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account